Medicines and Poisons (Medicines) Regulation 2021
sec.31Notification when starting and stopping treatment
Start here
Get a plain-English read of sec.31
Turn the raw legal text into a practical explanation grounded in Medicines and Poisons (Medicines) Regulation 2021.
sec.31 Notification when starting and stopping treatment
If the holder of a prescribing approval starts treating a patient under an opioid treatment program, the holder must ensure notice is given to the chief executive in the approved form. The notice must be given to the chief executive as soon as practicable, but no later than the end of the next business day, after the treatment starts. If the holder stops treating the patient, the holder must ensure notice is given to the chief executive in the approved form as soon as practicable, but no later than 3 business days, after the treatment stops. (sec.31-ssec.1) If the holder of a prescribing approval starts treating a patient under an opioid treatment program, the holder must ensure notice is given to the chief executive in the approved form. (sec.31-ssec.2) The notice must be given to the chief executive as soon as practicable, but no later than the end of the next business day, after the treatment starts. (sec.31-ssec.3) If the holder stops treating the patient, the holder must ensure notice is given to the chief executive in the approved form as soon as practicable, but no later than 3 business days, after the treatment stops.